 |
|
|
|
|
|
|
| The following information (Health Effects, Handling/Disposal, and Ingredients) is taken from the product label and/or the Material Safety Data Sheet (MSDS) prepared by the manufacturer. The National Library of Medicine does not test products nor does it evaluate information from the product label or the MSDS. (What is an MSDS?)
(Complete MSDS for this product)
|
 |
|
|
|
Health Effects
|
|
|---|
Warning! Combustible liquid and vapor. May affect the central nervous system causing dizziness, headache or nausea. Causes eye irritation. May cause skin and respiratory tract irritation. Harmful if swallowed.
|
From MSDS
Hazards Identification
Emergency Overview
Warning! Combustible liquid and vapor. May affect the central nervous system causing dizziness, headache or nausea. Causes eye irritation. May cause skin and respiratory tract irritation. Harmful if swallowed.
Potential Health Effects
Primary Route(s) of Entry: Inhalation, Skin absorption, Skin contact, Eye contact, Ingestion.
Eye contact: Can cause severe eye irritation. Symptoms include stinging, tearing, redness, and swelling of eyes. Can injure eye tissue.
Skin contact: Can cause skin irritation. Symptoms may include redness and burning of skin, and other skin damage.
Ingestion: Swallowing this material may be harmful. Liver, kidney and brain damage in humans has resulted from swallowing lethal or near-lethal amounts of ethylene glycol.
Inhalation: Breathing of vapor or mist is possible. Breathing small amounts of this material during normal handling is not likely to cause harmful effects. Breathing large amounts may be harmful. Symptoms are not expected at air concentrations below the recommended exposure limits, if applicable
Aggravated Medical Condition: Exposure to this material may aggravate any preexisting condition sensitive to a decrease in available oxygen, such as chronic lung disease, coronary artery disease or anemias., Preexisting disorders of the following organs (or organ systems) may be aggravated by exposure to this material:, lung (for example, asthma-like conditions), Liver, Kidney, Skin
|
From MSDS
No information provided.
|
This material is not listed as a carcinogen by the International Agency for Research on Cancer (IARC), the National Toxicology Program (NTP), or the Occupational Safety and Health Administration (OSHA).
|
Eye contact: If symptoms develop, immediately move individual away from exposure and into fresh air. Flush eyes gently with water for at least 15 minutes while holding eyelids apart; seek immediate medical attention.
Skin contact: Remove contaminated clothing. Flush exposed area with large amounts of water. If skin is damaged, seek immediate medical attention. If skin is not damaged and symptoms persist, seek medical attention. Launder clothing before reuse.
Ingestion: Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended.
Inhalation: If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention.
Notes to physician
Hazards: Effects of acute ethylene glycol poisoning appear in three fairly distinct stages. The initial stage occurs shortly after exposure, lasts 6-12 hours, and is characterized by central nervous system effects (transient exhilaration, nausea, vomiting, and in severe cases, coma, convulsions, and possible death). The second stage lasts from 12-36 hours after exposure and is initiated by the onset of coma. This phase is characterized by tachypnia, tachycardia, mild hypotension, cyanosis, and in severe cases, pulmonary edema, bronchopneumonia, cardiac enlargement, and congestive failure. The final stage occurs 24-72 post-exposure and is characterized by renal failure, ranging from a mild increase in blood urea nitrogen and creatinine followed by recovery, to complete anuria with acute tubular necrosis that can lead to death. Oxaluria is found in most cases. The most significant laboratory finding in ethylene glycol intoxication is severe metabolic acidosis. Treatment: This product contains ethylene glycol. Ethanol decreases the metabolism of ethylene glycol to toxic metabolites. Ethanol should be administered as soon as possible in cases of severe poisoning since the elimination half-life of ethylene glycol is 3 hours. If medical care will be delayed several hours, give the patient three to four 1-ounce oral "shots" of 86-proof or higher whiskey before or during transport to the hospital. Fomepizole (4-methylpyrazole) is an effective antagonist of alcohol dehydrogenase, and as such, may be used as an antidote in the treatment of ethylene glycol poisoning. Hemodialysis effectively removes ethylene glycol and its metabolites from the body.
|
| 2 |
| 2 |
| 0 |
0 = Minimal; 1 = Slight; 2 = Moderate; 3 = Serious; 4 = Severe;
N = No information provided by manufacturer; * = Chronic Health Hazard |
| 2011-09-21 |
|
|
|
|
|
|
|
|
Handling/Disposal
|
|---|
Containers of this material may be hazardous when emptied. Since emptied containers retain product residues (vapor, liquid, and/or solid), all hazard precautions given in the data sheet must be observed.
Store in a cool, dry, ventilated area.
|
Dispose of in accordance with all applicable local, state and federal regulations.
|
|
|
|
|
|
|
|
|
Ingredients from MSDS/Label
|
|---|
|
|
|
|
|
|
|
|
|
Home
| Brands | Manufacturers
| Ingredients | Health
Effects
|
|
